Unicorn AIM VCT Expands Share Base with New Equity Issue Under Ongoing Offer

AIM ImmunoTech Inc - Suspends Equity Distribution Agreement and Terminates Continuous Offering as of May 19, 2026 - SEC Filing

GrowGeneration CEO Darren Lampert buys 64,098 shares for $99,352.90

Aurora UK Alpha Increases Treasury Shares After Targeted Buyback

Canopy Growth Shares Fall After Disclosing Accounting Error, Plans Restatement of FY24, FY25 Results

Octopus AIM VCT 2 Secures Shareholder Backing at 2026 AGM

BRIEF-Aim Immunotech Announces Significant Increase In Stockholder Equity And Extension Of Promissory Note Maturity Date To June 2027

AIM ImmunoTech Strengthens Equity Position and Financial Flexibility

AIM ImmunoTech extends Streeterville promissory note maturity to June 30, 2027

AIM ImmunoTech Inc - Extends Promissory Note Maturity to June 30, 2027; Outstanding Balance $1.68 Mln

AIM ImmunoTech Announces Significant Increase in Stockholder Equity and Extension of Promissory Note Maturity Date to June 2027, Enhancing Financial Flexibility and Supporting Strategic Clinical Priorities

Harrow director Adrienne Graves acquires 1,000 common shares for $31,070

Harrow director Lauren Silvernail acquires $31,000 in common shares

Oberon AIM VCT Chair and Investment Manager Lift Stakes in Trust

Top Executive Makes Bold Move With Major Aurora Acquisition Stock Purchase

Aurora UK Alpha Updates Share Buyback and Voting Rights After Treasury Purchase

AIM Vaccine Reshapes Board with New Director Nominations After Resignation

AIM Vaccine Sets 2025 AGM to Approve Results, Board Changes and Capital Mandates

Teva Study Finds Only 23% of Younger Adults With Mood Disorders and Tardive Dyskinesia (TD) Symptoms Are Formally Diagnosed With TD Despite Widespread Impact

Dr. Reddy's Laboratories Slides Monday, Outperforms Competitors